Jüergen Braun (Jürgen Braun, J Braun, Juergen Braun)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 82

Top Venues

RMD open

The Journal of rheumatology

Annals of the rheumatic diseases

Therapeutic advances in musculoskeletal disease

Rheumazentrum Ruhrgebiet

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Rheumazentrum Ruhrgebiet Jan 01 2001

Germany

Medical director

Publications

David Kiefer, Lucia Schneider, Jüergen Braun, Uta Kiltz, Niklas Kolle, Ioana Andreica, Styliani Tsiami, Bjoern Bühring, Philipp Sewerin, Susanne Herbold, Xenofon Baraliakos
Clinically relevant differences in spinal mobility related to daytime performance in patients with axial spondyloarthritis. RMD open 10 (1) (2024)
Manouk de Hooge, Roos Stal, Alexandre Sepriano, Xenofon Baraliakos, Monique Reijnierse, Jüergen Braun, Désirée Mfm van der Heijde, Floris A van Gaalen, Josef S Smolen
Inflammation in the posterior elements, in particular the facet joint and facet joint ankylosis over 2-year follow-up in radiographic axial spondyloarthritis. RMD open 10 (2) (2024)
Weng Seng Warren Fong, Ting Hui Woon, Yu Heng Kwan, Jüergen Braun, Désirée Mfm van der Heijde, Annelies Boonen, Uta Kiltz
Comparison of the ASAS Health Index in patients classified as radiographic axial spondyloarthritis (axSpA) or non-radiographic axSpA in the ASAS Health Index international validation study. RMD open 10 (1) (2024)
David Kiefer, Lucia Schneider, Jüergen Braun, Uta Kiltz, Niklas Kolle, Ioana Andreica, Styliani Tsiami, Bjoern Bühring, Philipp Sewerin, Susanne Herbold, Xenofon Baraliakos
Clinically relevant differences in spinal mobility related to daytime performance in patients with axial spondyloarthritis. RMD open 10 (1) (2024)
Tim Pohlner, Dominik Deppe, Katharina Ziegeler, Fabian Proft, Mikhail Protopopov, Judith Rademacher, Valeria Rios Rodriguez, Murat Torğutalp, Jüergen Braun, Torsten Diekhoff, Denis Poddubnyy
Diagnostic accuracy in axial spondyloarthritis: a systematic evaluation of the role of clinical information in the interpretation of sacroiliac joint imaging. RMD open 10 (2) (2024)
David Kiefer, Lucia Schneider, Jüergen Braun, Uta Kiltz, Niklas Kolle, Ioana Andreica, Styliani Tsiami, Bjoern Buehring, Philipp Sewerin, Susanne Herbold, Xenofon Baraliakos
Impact of daily physical therapy over 2 weeks on spinal mobility including objective electronic measurements and function in patients with axial spondyloarthritis. Therapeutic advances in musculoskeletal disease 16 (2024)
Jüergen Braun, Elisabeth Märker-Hermann, Martin Rudwaleit, Joachim Sieper
HLA-B27 and the role of specific T cell receptors in the pathogenesis of spondyloarthritis. Annals of the rheumatic diseases (2024)
David Kiefer, Lucia Schneider, Jüergen Braun, Uta Kiltz, Niklas Kolle, Ioana Andreica, Styliani Tsiami, Bjoern Bühring, Philipp Sewerin, Susanne Herbold, Xenofon Baraliakos
Clinically relevant differences in spinal mobility related to daytime performance in patients with axial spondyloarthritis. RMD open 10 (1) (2024)
David Kiefer, Lucia Schneider, Jüergen Braun, Uta Kiltz, Niklas Kolle, Ioana Andreica, Styliani Tsiami, Bjoern Buehring, Philipp Sewerin, Susanne Herbold, Xenofon Baraliakos
Impact of daily physical therapy over 2 weeks on spinal mobility including objective electronic measurements and function in patients with axial spondyloarthritis. Therapeutic advances in musculoskeletal disease 16 (2024)
Weng Seng Warren Fong, Ting Hui Woon, Yu Heng Kwan, Jüergen Braun, Désirée Mfm van der Heijde, Annelies Boonen, Uta Kiltz
Comparison of the ASAS Health Index in patients classified as radiographic axial spondyloarthritis (axSpA) or non-radiographic axSpA in the ASAS Health Index international validation study. RMD open 10 (1) (2024)
Manouk de Hooge, Roos Stal, Alexandre Sepriano, Xenofon Baraliakos, Monique Reijnierse, Jüergen Braun, Désirée Mfm van der Heijde, Floris A van Gaalen, Josef S Smolen
Inflammation in the posterior elements, in particular the facet joint and facet joint ankylosis over 2-year follow-up in radiographic axial spondyloarthritis. RMD open 10 (2) (2024)
Manouk de Hooge, Roos Stal, Alexandre Sepriano, Xenofon Baraliakos, Monique Reijnierse, Jüergen Braun, Désirée Mfm van der Heijde, Floris A van Gaalen, Josef S Smolen
Inflammation in the posterior elements, in particular the facet joint and facet joint ankylosis over 2-year follow-up in radiographic axial spondyloarthritis. RMD open 10 (2) (2024)
Uta Kiltz, Xenofon Baraliakos, Jan Brandt-Jürgens, Ulf Wagner, Sebastian Lieb, Christian Sieder, Christian Mann, Jüergen Braun
Efficacy and NSAID-sparing effect of secukinumab 150 mg in ankylosing spondylitis: results from phase IV ASTRUM study. Therapeutic advances in musculoskeletal disease 16 (2024)
Imke Redeker, Stefan Moustakis, Styliani Tsiami, Xenofon Baraliakos, David Kiefer, Ioana Andreica, Björn Buehring, Jüergen Braun, Uta Kiltz
A Bayesian model to analyse the association of comorbidities with biosimilar treatment retention in a non-medical switch scenario in patients with inflammatory rheumatic musculoskeletal diseases. Arthritis research & therapy 26 (1) (2024)
Tim Pohlner, Dominik Deppe, Katharina Ziegeler, Fabian Proft, Mikhail Protopopov, Judith Rademacher, Valeria Rios Rodriguez, Murat Torğutalp, Jüergen Braun, Torsten Diekhoff, Denis Poddubnyy
Diagnostic accuracy in axial spondyloarthritis: a systematic evaluation of the role of clinical information in the interpretation of sacroiliac joint imaging. RMD open 10 (2) (2024)
Tim Pohlner, Dominik Deppe, Katharina Ziegeler, Fabian Proft, Mikhail Protopopov, Judith Rademacher, Valeria Rios Rodriguez, Murat Torğutalp, Jüergen Braun, Torsten Diekhoff, Denis Poddubnyy
Diagnostic accuracy in axial spondyloarthritis: a systematic evaluation of the role of clinical information in the interpretation of sacroiliac joint imaging. RMD open 10 (2) (2024)
Weng Seng Warren Fong, Ting Hui Woon, Yu Heng Kwan, Jüergen Braun, Désirée Mfm van der Heijde, Annelies Boonen, Uta Kiltz
Comparison of the ASAS Health Index in patients classified as radiographic axial spondyloarthritis (axSpA) or non-radiographic axSpA in the ASAS Health Index international validation study. RMD open 10 (1) (2024)
Uta Kiltz, Xenofon Baraliakos, Jan Brandt-Jürgens, Ulf Wagner, Sebastian Lieb, Christian Sieder, Christian Mann, Jüergen Braun
Efficacy and NSAID-sparing effect of secukinumab 150 mg in ankylosing spondylitis: results from phase IV ASTRUM study. Therapeutic advances in musculoskeletal disease 16 (2024)
Tim Pohlner, Dominik Deppe, Katharina Ziegeler, Fabian Proft, Mikhail Protopopov, Judith Rademacher, Valeria Rios Rodriguez, Murat Torğutalp, Jüergen Braun, Torsten Diekhoff, Denis Poddubnyy
Diagnostic accuracy in axial spondyloarthritis: a systematic evaluation of the role of clinical information in the interpretation of sacroiliac joint imaging. RMD open 10 (2) (2024)
David Kiefer, Lucia Schneider, Jüergen Braun, Uta Kiltz, Niklas Kolle, Ioana Andreica, Styliani Tsiami, Bjoern Bühring, Philipp Sewerin, Susanne Herbold, Xenofon Baraliakos
Clinically relevant differences in spinal mobility related to daytime performance in patients with axial spondyloarthritis. RMD open 10 (1) (2024)
Sabina Waldecker-Gall, Felix Seibert, Sebastian Bertram, Adrian Doevelaar, Jüergen Braun, Xenofon Baraliakos, Nina Babel, Christoph Waldecker, Linda Scharow, Nikolaos Pagonas, Timm H Westhoff
Dysfunctional high-density lipoprotein in chronic inflammatory rheumatic diseases. Therapeutic advances in musculoskeletal disease 15 (2023)
Jüergen Braun, Uta Kiltz, Xenofon Baraliakos
Emerging therapies for the treatment of spondyloarthritides with focus on axial spondyloarthritis. Expert opinion on biological therapy (2023)
Jüergen Braun, Uta Kiltz, Xenofon Baraliakos
Emerging therapies for the treatment of spondyloarthritides with focus on axial spondyloarthritis. Expert opinion on biological therapy 23 (2) (2023)
Jüergen Braun, Thomas Mairinger, Oliver Kaschke, Kai Behrendt, Josef Ramsbacher, Kirsten Karberg
Bilateral swelling of the salivary glands and sicca symptoms: an unusual differential diagnosis-Kimura's disease, a rare allergic condition with a high IgE serum level-a case report and review of the literature. RMD open 9 (2) (2023)
Jüergen Braun, Joachim Sieper
Fifty years after the discovery of the association of HLA B27 with ankylosing spondylitis. RMD open 9 (3) (2023)
David Kiefer, Jüergen Braun, Uta Kiltz, Varvara Chatzistefanidi, Daniela Adolf, Ilka Schwarze, Maria Kabelitz, Uwe Lange, Jan Brandt-Jürgens, Edgar Stemmler, Sabine Sartingen, Xenofon Baraliakos
Global functioning in axial spondyloarthritis is stronger associated with disease activity and function than with mobility and radiographic damage. Arthritis care & research (2023)
Désirée Mfm van der Heijde, Anna Moltó, Josef S Smolen, Jüergen Braun, Maxime Dougados, Floris A van Gaalen, Lianne S Gensler, Robert Davies Inman, Robert B M Landewe, Helena Marzo-Ortega, Victoria Navarro-Compán, Andri Phoka, Denis Poddubnyy, Mikhail Protopopov, John D Reveille, Martin Rudwaleit, Percival Sampaio-Barros, Alexandre Sepriano, Joachim Sieper, Filip E Van den Bosch, Irene van der Horst-Bruinsma, Pedro M Machado, Xenofon Baraliakos
Goodbye to the term 'ankylosing spondylitis', hello 'axial spondyloarthritis': time to embrace the ASAS-defined nomenclature. Annals of the rheumatic diseases (2023)
Mary Lucy Marques, Nuno Pereira da Silva, Désirée Mfm van der Heijde, Rosalinde Anne Stal, Xenofon Baraliakos, Jüergen Braun, Monique Reijnierse, Caroline Bastiaenen, Josef S Smolen, Floris A van Gaalen
Inflammation, bone loss and 2-year bone formation at the same vertebra in axial spondyloarthritis: a multilevel MRI and low-dose CT analysis. RMD open 9 (1) (2023)
Rosalinde Anne Stal, Josef S Smolen, Désirée Mfm van der Heijde, Floris A van Gaalen, Xenofon Baraliakos, Pedro M Machado, Manouk de Hooge, Rosaline van den Berg, Monique Reijnierse, Jüergen Braun, Robert B M Landewe, Alexandre Sepriano
Do fatty lesions explain the effect of inflammation on new syndesmophytes in patients with radiographic axial spondyloarthritis? Results from the SIAS cohort and ASSERT trial. RMD open 9 (3) (2023)
Jüergen Braun, Uta Kiltz, Xenofon Baraliakos
Emerging therapies for the treatment of spondyloarthritides with focus on axial spondyloarthritis. Expert opinion on biological therapy 23 (2) (2023)
Jüergen Braun, Uta Kiltz, Xenofon Baraliakos
Emerging therapies for the treatment of spondyloarthritides with focus on axial spondyloarthritis. Expert opinion on biological therapy (2023)
Mary Lucy Marques, Nuno Pereira da Silva, Désirée Mfm van der Heijde, Rosalinde Anne Stal, Xenofon Baraliakos, Jüergen Braun, Monique Reijnierse, Caroline Bastiaenen, Josef S Smolen, Floris A van Gaalen
Inflammation, bone loss and 2-year bone formation at the same vertebra in axial spondyloarthritis: a multilevel MRI and low-dose CT analysis. RMD open 9 (1) (2023)
Jüergen Braun, Laura C Coates
Axial spondyloarthritis and psoriatic arthritis: mostly overlapping or substantially different diseases? RMD open 9 (2) (2023)
Imke Redeker, Robert B M Landewe, Désirée Mfm van der Heijde, Josef S Smolen, Annelies Boonen, Maxime Dougados, Jüergen Braun, Uta Kiltz
Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohort. RMD open 9 (4) (2023)
Mary Lucy Marques, Nuno Pereira da Silva, Désirée Mfm van der Heijde, Rosalinde Anne Stal, Xenofon Baraliakos, Jüergen Braun, Monique Reijnierse, Caroline Bastiaenen, Josef S Smolen, Floris A van Gaalen
Inflammation, bone loss and 2-year bone formation at the same vertebra in axial spondyloarthritis: a multilevel MRI and low-dose CT analysis. RMD open 9 (1) (2023)
Imke Redeker, Stefan Moustakis, Styliani Tsiami, Xenofon Baraliakos, Ioana Andreica, Bjoern Buehring, Jüergen Braun, Uta Kiltz
Treatment with adalimumab in patients with chronic inflammatory rheumatic diseases: a study of treatment trajectories on a patient level in routine care. Therapeutic advances in musculoskeletal disease 15 (2023)
Jüergen Braun, Laura C Coates
Axial spondyloarthritis and psoriatic arthritis: mostly overlapping or substantially different diseases? RMD open 9 (2) (2023)
Imke Redeker, Robert B M Landewe, Désirée Mfm van der Heijde, Josef S Smolen, Annelies Boonen, Maxime Dougados, Jüergen Braun, Uta Kiltz
Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohort. RMD open 9 (4) (2023)
Jüergen Braun
Correspondence on "ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update" by Ramiro et al . Annals of the rheumatic diseases (2023)
Imke Redeker, Robert B M Landewe, Désirée Mfm van der Heijde, Josef S Smolen, Annelies Boonen, Maxime Dougados, Jüergen Braun, Uta Kiltz
Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohort. RMD open 9 (4) (2023)
Jüergen Braun, Uta Kiltz, Xenofon Baraliakos
Emerging therapies for the treatment of spondyloarthritides with focus on axial spondyloarthritis. Expert opinion on biological therapy 23 (2) (2023)
Ioana Andreica, Iulia Roman, Imke Redeker, Xenofon Baraliakos, Jüergen Braun, Uta Kiltz
Facilitators and barriers for vaccination in patients with inflammatory rheumatic musculoskeletal diseases: a prospective cohort study. RMD open 9 (2) (2023)
Jüergen Braun, Thomas Mairinger, Oliver Kaschke, Kai Behrendt, Josef Ramsbacher, Kirsten Karberg
Bilateral swelling of the salivary glands and sicca symptoms: an unusual differential diagnosis-Kimura's disease, a rare allergic condition with a high IgE serum level-a case report and review of the literature. RMD open 9 (2) (2023)
Mary Lucy Marques, Nuno Pereira da Silva, Désirée Mfm van der Heijde, Rosalinde Anne Stal, Xenofon Baraliakos, Jüergen Braun, Monique Reijnierse, Caroline Bastiaenen, Josef S Smolen, Floris A van Gaalen
Inflammation, bone loss and 2-year bone formation at the same vertebra in axial spondyloarthritis: a multilevel MRI and low-dose CT analysis. RMD open 9 (1) (2023)
Uta Kiltz, Eerik Ahomaa, Salima F E van Weely, David Kiefer, Bjoern Bühring, Xenofon Baraliakos, Jüergen Braun
Clinically Relevant Deficits in Performance Tests in Patients With Axial Spondyloarthritis. The Journal of rheumatology (2022)
Bjoern Bühring, Nadine Al-Azem, Uta Kiltz, Martin Fruth, Ioana Andreica, David Kiefer, Styliani Tsiami, Xenofon Baraliakos, Jüergen Braun
High Prevalence of Foot Insufficiency Fractures in Patients With Inflammatory Rheumatic Musculoskeletal Diseases. The Journal of rheumatology (2022)
Jüergen Braun
Significance of structural changes in the axial skeleton in patients with axial spondyloarthritis: how important are lesions in the sacroiliac joint? RMD open 8 (2) (2022)
Rosalinde Anne Stal, Xenofon Baraliakos, Désirée Mfm van der Heijde, Floris A van Gaalen, Josef S Smolen, Rosaline van den Berg, Monique Reijnierse, Jüergen Braun, Robert B M Landewe, Alexandre Sepriano
Role of vertebral corner inflammation and fat deposition on MRI on syndesmophyte development detected on whole spine low-dose CT scan in radiographic axial spondyloarthritis. RMD open 8 (2) (2022)
Casper Webers, Uta Kiltz, Jüergen Braun, Désirée Mfm van der Heijde, Annelies Boonen
The effect of anti-inflammatory treatment on depressive symptoms in spondyloarthritis: does the type of drug matter? Rheumatology (Oxford, England) (2022)
Mary Lucy Marques, Nuno Pereira da Silva, Désirée Mfm van der Heijde, Monique Reijnierse, Xenofon Baraliakos, Jüergen Braun, Floris A van Gaalen, Josef S Smolen
Low-dose CT hounsfield units: a reliable methodology for assessing vertebral bone density in radiographic axial spondyloarthritis. RMD open 8 (2) (2022)
Rosalinde Anne Stal, Alexandre Sepriano, Floris Alexander van Gaalen, Xenofon Baraliakos, Rosaline van den Berg, Monique Reijnierse, Jüergen Braun, Robert B M Landewé, Désirée Mfm van der Heijde
Associations between syndesmophytes and facet joint ankylosis in radiographic axial spondyloarthritis patients on low-dose CT over 2 years. Rheumatology (Oxford, England) 61 (12) (2022)
Martin Krekeler, Xenofon Baraliakos, Styliani Tsiami, Jüergen Braun
High prevalence of chondrocalcinosis and frequent comorbidity with calcium pyrophosphate deposition disease in patients with seronegative rheumatoid arthritis. RMD open 8 (2) (2022)
Jüergen Braun, Uta Kiltz, Atul Deodhar, Tetsuya Tomita, Maxime Dougados, Rebecca Bolce, David Sandoval, Chen-Yen Lin, Jessica Walsh
Efficacy and safety of ixekizumab treatment in patients with axial spondyloarthritis: 2-year results from COAST. RMD open 8 (2) (2022)
Uta Kiltz, Eerik P Ahomaa, Salima F E van Weely, David Kiefer, Bjoern Bühring, Xenofon Baraliakos, Jüergen Braun
Clinically Relevant Deficits in Performance Tests in Patients With Axial Spondyloarthritis. The Journal of rheumatology 50 (3) (2022)
Dietmar Krause, Anna Mai, Renate Klaassen-Mielke, Nina Timmesfeld, Ulrike Trampisch, Henrik Rudolf, Xenofon Baraliakos, Elmar Schmitz, Claas Fendler, Claudia Klink, Stephanie Boeddeker, Ertan Saracbasi-Zender, Hans-Joachim Christoph, Manfred Igelmann, Hans-Juergen Menne, Albert Schmid, Rolf Rau, Siegfried Wassenberg, Nilüfer Sonuc, Claudia Ose, Carmen Schade-Brittinger, Hans J Trampisch, Jüergen Braun
The Efficacy of Short-Term Bridging Strategies With High- and Low-Dose Prednisolone on Radiographic and Clinical Outcomes in Active Early Rheumatoid Arthritis: A Double-Blind, Randomized, Placebo-Controlled Trial. Arthritis & rheumatology (Hoboken, N.J.) 74 (10) (2022)
Jüergen Braun, X Baraliakos, R Bülow, C O Schmidt, A Richter
Striking sex differences in magnetic resonance imaging findings in the sacroiliac joints in the population. Arthritis research & therapy 24 (1) (2022)
Dietmar Krause, Jüergen Braun
Reply. Arthritis & rheumatology (Hoboken, N.J.) (2022)
Jüergen Braun
Significance of structural changes in the axial skeleton in patients with axial spondyloarthritis: how important are lesions in the sacroiliac joint? RMD open 8 (2) (2022)
Jüergen Braun, Uta Kiltz, Xenofon Baraliakos
Management of Axial Spondyloarthritis - Insights into Upadacitinib. Drug design, development and therapy 16 (2022)
Jüergen Braun
Significance of structural changes in the axial skeleton in patients with axial spondyloarthritis: how important are lesions in the sacroiliac joint? RMD open 8 (2) (2022)
Robin Kempin, Jutta G Richter, Anna Schlegel, Xenofon Baraliakos, Styliani Tsiami, Bjoern Buehring, David Kiefer, Jüergen Braun, Uta Kiltz
Monitoring of Disease Activity With a Smartphone App in Routine Clinical Care in Patients With Axial Spondyloarthritis. The Journal of rheumatology 49 (8) (2022)
Jüergen Braun
Significance of structural changes in the axial skeleton in patients with axial spondyloarthritis: how important are lesions in the sacroiliac joint? RMD open 8 (2) (2022)
Robert B M Landewe, Jüergen Braun
Response to: Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'?' by Braun and Landewé. Annals of the rheumatic diseases (2022)
Uta Kiltz, Eerik P Ahomaa, Salima F E van Weely, David Kiefer, Bjoern Bühring, Xenofon Baraliakos, Jüergen Braun
Clinically Relevant Deficits in Performance Tests in Patients With Axial Spondyloarthritis. The Journal of rheumatology 50 (3) (2022)
Jüergen Braun
Significance of structural changes in the axial skeleton in patients with axial spondyloarthritis: how important are lesions in the sacroiliac joint? RMD open 8 (2) (2022)
Uta Kiltz, Eerik P Ahomaa, Salima F E van Weely, David Kiefer, Bjoern Bühring, Xenofon Baraliakos, Jüergen Braun
Clinically Relevant Deficits in Performance Tests in Patients With Axial Spondyloarthritis. The Journal of rheumatology 50 (3) (2022)
Jüergen Braun, Robert B M Landewe
Response to: Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physicianreported spondylitis'?' by Braun and Landewe. Annals of the rheumatic diseases (2021)
Imke Redeker, Katinka Albrecht, Joern Kekow, Gerd-Rüdiger R Burmester, Jüergen Braun, Martin Schäfer, Angela Zink, Anja Strangfeld
Risk of herpes zoster (shingles) in patients with rheumatoid arthritis under biologic, targeted synthetic and conventional synthetic DMARD treatment: data from the German RABBIT register. Annals of the rheumatic diseases (2021)
Jüergen Braun, Ricardo Blanco, Helena Marzo-Ortega, Lianne S Gensler, Filip van den Bosch, Stephen Hall, Hideto Kameda, Denis Poddubnyy, Marleen van de Sande, Anna S Wiksten, Brian O Porter, Abhijit Shete, Hanno B Richards, Sibylle Haemmerle, Atul Deodhar
Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENT. Arthritis research & therapy 23 (1) (2021)
Jüergen Braun, Uta Kiltz, Björn Bühring, Xenofon Baraliakos
Secukinumab in axial spondyloarthritis: a narrative review of clinical evidence. Therapeutic advances in musculoskeletal disease 13 (2021)
Jüergen Braun, Xenofon Baraliakos, Uta Kiltz
Treat-to-target in axial spondyloarthritis - what about physical function and activity? Nature reviews. Rheumatology 17 (9) (2021)
Jüergen Braun, Uta Kiltz, Xenofon Baraliakos
Significance of structural changes in the sacroiliac joints of patients with axial spondyloarthritis detected by MRI related to patients symptoms and functioning. Annals of the rheumatic diseases (2021)
Jüergen Braun, Robert B M Landewe
No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'? Annals of the rheumatic diseases (2021)
Uta Kiltz, Daniel Wendling, Jüergen Braun
Dr. Kiltz, et al reply. The Journal of rheumatology 48 (5) (2021)
Uta Kiltz, Jüergen Braun
Correspondence on "Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial" by Molto et al. Annals of the rheumatic diseases (2021)
Jüergen Braun, Bjoern Buehring, Xenofon Baraliakos, Lianne S Gensler, Brian Porter, Erhard Quebe-Fehling, Sibylle Haemmerle
Effects of secukinumab on bone mineral density and bone turnover biomarkers in patients with ankylosing spondylitis: 2-year data from a phase 3 study, MEASURE 1. BMC musculoskeletal disorders 22 (1) (2021)
Timm Henning Westhoff, Felix S Seibert, Moritz Anft, Arturo Blazquez-Navarro, Sarah Skrzypczyk, Adrian Doevelaar, Bodo Hölzer, Krystallenia Paniskaki, Sebastian Dolff, Benjamin Wilde, Oliver Witzke, Jüergen Braun, Ulrik Stervbo, Nina Babel
Correspondence on 'SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response'. Annals of the rheumatic diseases 80 (10) (2021)
Xenofon Baraliakos, A Ghadir, Martin Fruth, Uta Kiltz, Imke Redeker, Jüergen Braun
Which Magnetic Resonance Imaging Lesions in the Sacroiliac Joints Are Most Relevant for Diagnosing Axial Spondyloarthritis? A Prospective Study Comparing Rheumatologists' Evaluations With Radiologists' Findings. Arthritis & rheumatology (Hoboken, N.J.) 73 (5) (2021)
Uta Kiltz, James Cheng-Chung Wei, Désirée Mfm van der Heijde, Filip E Van den Bosch, Jessica A Walsh, Annelies Boonen, Lianne S Gensler, Theresa Hunter, Hilde Carlier, Yan Dong, Xiaoqi Li, Rebecca Bolce, Vibeke Strand, Jüergen Braun
Ixekizumab Improves Functioning and Health in the Treatment of Radiographic Axial Spondyloarthritis: Week 52 Results from 2 Pivotal Studies. The Journal of rheumatology 48 (2) (2020)
Uta Kiltz, Daniel Wendling, Jüergen Braun
ASAS Health Index: The "All in One" for Spondyloarthritis Evaluation? The Journal of rheumatology 47 (10) (2020)
Jüergen Braun, H Haibel, M de Hooge, R Landewé, M Rudwaleit, T Fox, A Readie, H B Richards, B Porter, R Martin, D Poddubnyy, J Sieper, D van der Heijde
Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison. Arthritis research & therapy 21 (1) (2019)
Jüergen Braun, Xenofon Baraliakos, Uta Kiltz, Klaus Krüger, Gerd-Rüdiger R Burmester, Siegfried Wassenberg, Matthias H Thomas
Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor Inhibitor Therapy in Ankylosing Spondylitis: A German GO-NICE Study Subanalysis. The Journal of rheumatology 47 (1) (2019)

Jüergen Braun.css-eqlu8i{font-size:small;padding-left:4px;} (Jürgen Braun, J Braun, Juergen Braun)

Publication Activity (10 Years)

Top Topics

Top Venues

Jüergen Braun (Jürgen Braun, J Braun, Juergen Braun)